Patient–delivered partner medication: the antagonism of clinical standards and good medical practice

Coyne KM , Cohen CE , Smith NA. Patient-delivered partner medication in the UK: an unlawful but popular choice. Int J STD AIDS 2007; 18: 829–31.

Cameron ST , Melvin L , Glasier A. Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of women with Chlamydia. BJOG 2007; 114: 1516–21.

Stekler J , Bachmann L , Brotman RM. Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy. Clin Infect Dis 2005; 40: 787–93.

Schillinger JA , Kissinger P , Calvet H. Patient-delivered partner treatment with azithromyicn to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003; 30: 49–56.

Nuwaha F , Kambugu F , Nsubuga PS. Efficacy of patient-delivered partner medication in the treatment of sexual partners in Uganda. Sex Transm Dis 2001; 28: 105–10.

Kissinger P , Brown R , Reed K. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect 1998; 74: 331–3.

Khan A , Fortenberry JD , Juliar BE. The prevalence of Chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment. Sex Transm Dis 2005; 32: 260–4.

Health Protection Agency. Testing Times: HIV and other sexually transmitted infections in the United Kingdom 2007: HIV and other STI. -2-1 HIV. See [www.hpa.org.uk]

Markos AR. The concordance of Chlamydia trachomatis genital infection between sexual partners, in the era of nucleic acid testing. Sex Health 2005; 2: 23–4.

NICE. Preventing sexually transmitted infections and reducing under 18 conceptions: One to one interventions to reduce the transmission of sexually transmitted infections (STIs) including HIV. See [www.nice.org.uk]

GMC. Good practice in prescribing medicines: presenting in patients’ best interest. See [www.gmc.uk.org/guidance]